A new life-sized Gardevoir plush was announced by the Pokemon Center Japan for approximately $319. The Pokemon franchise expands to merchandise like Funko Pops, t-shirts, and keychains.

A life-sized Gardevoir plush will be available for purchase, standing over 160 cm tall. The plush costs 49,500 yen and is only announced for sale in Japan. It will be unsettling to have a large ...

“Obviously, they clearly had people in that room with common sense,” Clark said, via Awful Announcing. “It’s no disrespect to Eli Manning. I’m not gonna be in the Hall of Fame ...

The 19-year-old phenom, who is set to finally take over as a starter in the 2025 season, said he has been bullied by his famous uncles, Peyton and Eli, and they have even given him wedgies.

Getty Images Pharmaceutical company Eli Lilly is expected to report fourth-quarter earnings before the bell Thursday. Analysts tracking the company see increased sales and profit for Eli Lilly in ...

Read our editorial standards for more information. Eli Manning prevailed during the FanDuel Kick of Destiny on Sunday. During the Super Bowl 2025 pre-game show on Fox, the former Giants ...

Eli Manning was obviously snubbed by missing out on the Pro Football Hall of Fame class of 2025, but the former New York Giants great is taking it well. In fact, he had a really classy reaction to ...

Many expected Peyton and Eli Manning to achieve that milestone in 2025, but it’s actually Sterling and Shannon who made history," NFL reporter Ari Meirov pointed out. Peyton was inducted into ...

Caitlin Clark had a terrific Sunday afternoon. The University of Iowa women’s basketball program immortalized Clark’s career forever as they officially retired her No. 22 jersey and hung it in ...

It’s the smallest Hall of Fame class in 20 years. Not making the cut: Eli Manning. The former New York Giants quarterback, a two-time Super Bowl MVP, was bypassed by the 49-member selection ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.